Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Aidan P Noon"'
Autor:
Oliver Reed, Ibrahim Jubber, Jon Griffin, Aidan P Noon, Louise Goodwin, Syed Hussain, Marcus G Cumberbatch, James W F Catto
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0239338 (2020)
ObjectivesUp to 10% of Bladder Cancers may arise following occupational exposure to carcinogens. We hypothesised that different cancer phenotypes reflected different patterns of occupational exposure.MethodsConsecutive participants, with bladder canc
Externí odkaz:
https://doaj.org/article/915d7f21a1be4f5a818267ee19d14c2c
Autor:
Samantha Conroy, Karl Pang, Ibrahim Jubber, Syed A. Hussain, Derek J. Rosario, Marcus G. Cumberbatch, James W. F. Catto, Aidan P. Noon
Publikováno v:
BJUI Compass, Vol 4, Iss 3, Pp 314-321 (2023)
Abstract Objectives The objectives of the study are to explore tolerability, acceptability and oncological outcomes for patients with high‐risk non‐muscle‐invasive bladder cancer (NMIBC) treated with hyperthermic intravesical chemotherapy (HIVE
Externí odkaz:
https://doaj.org/article/7deccf3d139a419ca0e9c8203bc819f4
Autor:
Samantha Conroy, Karl Pang, Ibrahim Jubber, Syed A. Hussain, Derek J. Rosario, Marcus G. Cumberbatch, James W. F. Catto, Aidan P. Noon
Publikováno v:
BJUI Compass. 4:314-321
Autor:
Samantha Conroy, Rachel Hubbard, Aidan P. Noon, Syed A. Hussain, Jon Griffin, Steven Kennish, James W. F. Catto
Publikováno v:
BJU international. 129(6)
Autor:
Atiqullah Aziz, Felix K.-H. Chun, Kees Hendricksen, Jakub Dobruch, Morgan Rouprêt, Evanguelos Xylinas, Shahrokh F. Shariat, Paolo Gontero, Bas W.G. van Rhijn, Andrea Necchi, Roland Seiler, Brian Qvick, Michael Rink, Florian Roghmann, Luis A. Kluth, Marek Babjuk, Perrine Bes, Aidan P. Noon
Publikováno v:
European Urology Focus. 5:681-688
Background The European Association of Urology (EAU) non–muscle-invasive bladder cancer (NMIBC) guidelines are meant to help minimise morbidity and improve the care of patients with NMIBC. However, there may be underuse of guideline-recommended car
Autor:
Karl H. Pang, Aidan P. Noon
Publikováno v:
Translational Andrology and Urology
Bladder cancer (BC) is a common disease in both sexes and majority of cases present as non-muscle invasive BC (NMIBC). The percentage of NMIBC progressing to muscle invasive BC (MIBC) varies between 25% and 75% and currently there are no reliable mol
Autor:
Marcus G. Cumberbatch, Aidan P. Noon
Publikováno v:
Translational Andrology and Urology
Bladder cancer (BC) is a common, significant and expensive health condition. Understanding the risk factors for this disease is paramount to improving disease prevention and increasing public awareness. Historically BC has been a disease of industria
Autor:
Matt Simms, Samantha Conroy, Michelle Collinson, Richard W. Bell, Mark I. Johnson, Rohit Chahal, Kathryn Gordon, Phillip Koenig, Mohantha Dooldeniya, Heather Poad, Maureen Twiddy, Julie Croft, James W.F. Catto, Julia Brown, Louise Goodwin, Aidan P. Noon, Sunjay Jain
Publikováno v:
Journal of Clinical Oncology
PURPOSE High-grade nonmuscle invasive bladder cancer (HRNMIBC) is a heterogeneous disease. Treatments include intravesical maintenance Bacillus Calmette-Guerin (mBCG) and radical cystectomy (RC). We wanted to understand whether a randomized trial com
Publikováno v:
European Urology Focus. 4:725-730
Background We examined a national data set to determine if workers employed in specific occupations develop distinct bladder cancer (BCa) phenotypes. Objective To compare the incidence and disease-specific mortality (DSM) of localized and advanced BC
Publikováno v:
European Urology. 73:363-371
Background Multimodal enhanced recovery after surgery (ERAS) regimens have improved outcomes from colorectal surgery. Objective We report the application of ERAS to patients undergoing radical cystectomy (RC). Design, setting, and participants Prospe